Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

Clinical trial NCT01289119 · COMPLETED

Trial details

NCT number: NCT01289119
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-12-01
Primary completion: 2011-12-01
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.